Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MAGED F AYAD

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1992718332
CMS profile
362543
Location
BURBANK, CA

General Payments · PY2018–2024

$4,142.97

  • Reported across 182 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$432.38

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $432.38 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Cook Medical LLC $132.22 1
Acerta Pharma LLC $68.24 3
Abbott Laboratories $48.89 2
GlaxoSmithKline, LLC. $48.58 2
Amgen Inc. $31.11 1
Antares Pharma, Inc. $30.78 1
Exact Sciences Corporation $27.04 1
Lilly USA, LLC $26.86 1
PFIZER INC. $18.66 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $900.24 41
PY2019 $809.85 41
PY2020 $424.84 19
PY2021 $723.25 32
PY2022 $388.43 17
PY2023 $463.98 19
PY2024 $432.38 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $24.15 06/26/2024 Food and Beverage Undisputed 01/23/2026 1125379206 CMS
Abbott Laboratories $24.74 11/11/2024 Food and Beverage Undisputed 01/23/2026 1125379208 CMS
Amgen Inc. $31.11 01/10/2024 Food and Beverage Undisputed 01/23/2026 1117194292 CMS
Antares Pharma, Inc. $30.78 06/27/2024 Food and Beverage Undisputed 01/23/2026 1146448086 CMS
AstraZeneca Pharmaceuticals LP $27.80 06/14/2024 Food and Beverage Undisputed 01/23/2026 1105320248 CMS
AstraZeneca Pharmaceuticals LP $16.32 06/18/2024 Food and Beverage Undisputed 01/23/2026 1104546982 CMS
AstraZeneca Pharmaceuticals LP $24.12 09/18/2024 Food and Beverage Undisputed 01/23/2026 1105514181 CMS
Cook Medical LLC $132.22 02/01/2024 Food and Beverage Undisputed 01/23/2026 1118332635 CMS
Exact Sciences Corporation $27.04 02/28/2024 Food and Beverage Undisputed 01/23/2026 1114581666 CMS
GlaxoSmithKline, LLC. $24.22 03/13/2024 Food and Beverage Undisputed 01/23/2026 1116514093 CMS
GlaxoSmithKline, LLC. $24.36 08/21/2024 Food and Beverage Undisputed 01/23/2026 1116490298 CMS
Lilly USA, LLC $26.86 04/03/2024 Food and Beverage Undisputed 01/23/2026 1135162627 CMS
PFIZER INC. $18.66 04/23/2024 Food and Beverage Undisputed 01/23/2026 1131313608 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.